Monday, June 17, 2024

AI Small Cap Revolutionizing The Health-Care Tech Race (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP)

Date:

PredictMedix AI (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) is an emerging provider of rapid health screening and remote patient care solutions globally — the Company’s Safe Entry Stations — powered by a proprietary artificial intelligence (AI) technology.

The technology uses multispectral cameras to analyze physiological data patterns and predict various health issues, including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue or various mental illnesses.

Defies logic why this Company does not have a higher stock price. I’ll get into some reasons for that in a moment. First, a quote from the COO;

“Predictmedix AI’s Safe Entry Stations showcase the effective merging of technology and healthcare in the realm of healthcare innovation. Driven by our dedication to advancing patient care and operational efficiency, we are shaping a new paradigm in healthcare practices.

By automating screening processes and optimizing resource utilization, our Safe Entry Stations offer tangible cost savings and the assurance of enhanced patient safety and well-being. The evolution of Safe Entry holds promise for our Company and shareholders as we continue to shape valuable contributions within the healthcare sector and drive positive change,” commented Dr. Rahul Kushwah, COO of Predictmedix AI.

Forbes notes that adopting AI could lead to savings of 5% to 10% in US healthcare spending — roughly $200 billion to $360 billion annually in 2019 dollars — within the next five years, according to a paper recently published by the National Bureau of Economic Research.

Investors may have been reluctant to invest as the tech is developed and tested in India, and there needs to be more knowledge and even ignorance regarding India’s vast role.

“Some of the latest medical technologies in India include robotic surgery, artificial intelligence in healthcare, telemedicine, 3D Printing and innovative wound care devices. Leading the industry SS Innovations has developed India’s first robotic system that can be used in a variety of surgeries” (India Times, May 23rd, 2023)

The CAGR of the Indian Healthcare industry is 23%. Medical Tourism is experiencing 25% growth, and the industry has doubled from $3 billion in 2017 to $8 billion.

Too good to be true may be another roadblock. Maybe not.

So now that’s dealt with back, to Predictmedix. One of the most recent PR notes that using its Safe Entry Station, AI-based tech, the Company completed 200,000 scans. I hate to be quote heavy, but PMED’s quotes are newsy and direct, unlike many companies. Most folks in C-Suites can’t describe their service/product to each other, let alone investors. Not so PMED:

“The data collected from Safe Entry’s scans has significantly advanced our machine learning capabilities, allowing us to offer more precise and reliable solutions to the healthcare industry. This extensive dataset provides an unprecedented opportunity to gain deeper insights into various health indicators and trends, enabling a more comprehensive understanding of human health. Moreover, this rich data trove serves as a powerful resource for medical research and innovation, allowing experts to explore new avenues for disease prevention, early detection, and personalized healthcare solutions,” commented Dr. Rahul Kushwah, COO of PredictMedix AI.

Courtesy of PMED’S AI tech, a company with great potential should quickly grow and be a significant, if not a vital, resource for other companies. I imagine we’ll see some soon in ERs and doctor’s offices, which makes eminent sense for enhancing healthcare and massive cost savings.

As I said, I don’t know why the shares are so low. BTW, I own some.

Bob Beaty
+ posts

For over 30 years, Bob Beaty has been explaining concepts and companies to the global investment community. One of the original writers for Jim Cramer’s Thestreet.com, he also wrote for AOL (Can/US), the Globe and Mail, and the Huffington Post. Over that period, he illuminated small-cap companies to investors with wit and pith but mostly opinion and facts. Investing should be fun. Pedantic, staid content is no fun.

Before embarking on his writing career, Bob had a successful international journey in the finance industry. He served as a broker, derivatives product manager, and a Director of London's Credit Suisse subsidiary. His career spanned across major financial hubs including Toronto, Vancouver, and the UK, giving him a unique global perspective. (He is still fondly remembering those English client lunches.)

Other than everything Groucho Marx and George Carlin ever said, Bob lives by a simple credo;

‘Never do anything the person standing in front of you can't understand.’ Hunter S. Thompson.

Let’s go.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_img

Popular

More like this
Related

An Environmental Proxy in the Growing Lubricant Market (OTC PINK: MEIL)

Methes Energies International Ltd. (OTC PINK: MEIL) reformulates its lubricants to...

Discover Why You Have to Join Golden Rapture’s Journey

Golden Rapture's recent sampling at Phillips Township yielded significant...

Element79 Gold’s Strategic Asset Optimization Paves the Way for Growth

Element79 Gold Corp. (CSE: ELEM) (OTC: ELMGF) (FSE: 7YS)...

Methes Energies is Pioneering Sustainable Bio-Lubricants and Biodiesel Fuels

Methes Energies is releasing reformulated bio-lubricants in mid-2024, enhancing...